Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Patients with type 2 diabetesa common indication for GLP-1 therapymay already have compromised kidney function, making adequate hydration and monitoring even more important
As the medication promotes significant reductions in body weightwith clinical trials showing 10-15% weight loss in type 2 diabetes and up to 20% in obesity trialspatients lose adipose tissue which serves as insulation
Least squares mean (LSM) difference (standard error (SE)) for pairwise comparison between tirzepatide groups and placebo was calculated using analysis of covariance (ANCOVA) with the last observation carried forward (LOCF) for imputation of missing data at week 72
If you are ready to take the next step in your metabolic health journey, the best place to start is with our free assessment quiz
Prepare the Vials: Pop the protective plastic caps off both vials
